1. Home
  2. PRIM vs PCVX Comparison

PRIM vs PCVX Comparison

Compare PRIM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

N/A

Current Price

$103.72

Market Cap

6.7B

Sector

Industrials

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$46.72

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRIM
PCVX
Founded
1960
2013
Country
United States
United States
Employees
18526
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.0B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
PRIM
PCVX
Price
$103.72
$46.72
Analyst Decision
Buy
Strong Buy
Analyst Count
15
4
Target Price
$155.20
$88.25
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
0.19%
N/A
EPS Growth
51.66
N/A
EPS
0.32
N/A
Revenue
N/A
N/A
Revenue This Year
$9.92
N/A
Revenue Next Year
$8.80
N/A
P/E Ratio
$383.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.84
$29.10
52 Week High
$205.50
$65.00

Technical Indicators

Market Signals
Indicator
PRIM
PCVX
Relative Strength Index (RSI) 35.39 37.28
Support Level $100.83 $46.39
Resistance Level $122.33 $49.46
Average True Range (ATR) 8.44 1.94
MACD 0.55 -0.03
Stochastic Oscillator 9.42 18.82

Price Performance

Historical Comparison
PRIM
PCVX

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of critical infrastructure services operating mainly in the United States and Canada. The company provides a range of construction, maintenance, replacement, and engineering services. The Utilities segment operates throughout the United States and specializes in a range of services, including the construction and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communications systems. The Energy segment operates throughout the United States and Canada and specializes in a range of services that include engineering, procurement, construction, and maintenance services to various industries. The majority of the company's revenue is derived from the Energy segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: